Shopping Cart
- Remove All
Your shopping cart is currently empty
5-HT6/7 antagonist 1
🥰Excellent
Catalog No. T61807Cas No. 131999-28-5
5-HT6/7 antagonist 1 is a dual 5-HT6/7/2A and D2 receptor antagonist used in the study of dementia and Alzheimer's disease.
5-HT6/7 antagonist 1
🥰Excellent
Purity: 98.78%
Catalog No. T61807Cas No. 131999-28-5
5-HT6/7 antagonist 1 is a dual 5-HT6/7/2A and D2 receptor antagonist used in the study of dementia and Alzheimer's disease.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $700 | In Stock | |
| 5 mg | $1,800 | In Stock | |
| 25 mg | $3,580 | In Stock | |
| 50 mg | $4,860 | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "5-HT6/7 antagonist 1"
Alverine citrate
NSC 35459
T04285560-59-8
Alverine citrate (NSC 35459) is utilized in functional gastrointestinal disorders.
- $41
Size
QTY
Dapoxetine hydrochloride
LY-210448 hydrochloride, Dapoxetine HCl
T6461129938-20-1
Dapoxetine hydrochloride (LY-210448 hydrochloride) is a selectivity short-acting serotonin reuptake inhibitor, used for the therapy of premature ejaculation.
- $30
Size
QTY
Octopamine hydrochloride
(±)-p-Octopamine hydrochlorid, (+,-)-Octopamine HCl
T0469770-05-8
Octopamine hydrochloride ((±)-p-Octopamine hydrochlorid) is a biogenic monoamine structurally associated with noradrenaline. It can serve as a neurohormone, a neurotransmitter, and a neuromodulator in invertebrates.
- $45
Size
QTY
Oxolinic acid
Urinox, NSC 110364, Nidantin, Emyrenil, Dioxacin
T123314698-29-4
Oxolinic acid (Nidantin) is a synthetic antimicrobial related to NALIDIXIC ACID and used in URINARY TRACT INFECTIONS.
- $34
Size
QTY
Trazodone hydrochloride
Trazodone HCl, KB-831, AF-1161
T161925332-39-2
Trazodone hydrochloride (Trazodone HCl) is a serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety.
- $39
Size
QTY
Clozapine N-Oxide
Cited
T449434233-69-7
Clozapine N-oxide is the major metabolite of Clozapine and is blood-brain barrier permeable. Clozapine N-oxide is an agonist of DREADDs and activates the DREADD receptors hM3Dq and hM4Di. Clozapine N-oxide is also a dopamine antagonist and selective muscarinic M4 receptor agonist.
- $30
Size
QTY
CitedMianserin hydrochloride
ORG GB-94 HCl, Mianserin HCl
T078321535-47-7
Mianserin hydrochloride (Org GB 94) is a tetracyclic compound with antidepressant properties that blocks alpha-adrenergic, histamine H1, and certain serotonin receptors; it may cause drowsiness and hematological issues.
- $30
Size
QTY
Citicoline Cited
cytidine diphosphate-choline, cytidine 5'-diphosphocholine, Citicholine, CDP-Choline
T0136987-78-0
Citicoline (CDP-Choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects.
- $30
Size
QTY
CitedCinchonidine
α-Quinidine, L-Cinchonidine
T1317485-71-2
Cinchonidine (L-Cinchonidine) is an alkaloid extracted from Cinchona officinalis. It is a pseudo-enantiomer and stereoisomer of cinchonine.
- $31
Size
QTY
Amitriptyline hydrochloride
Tryptizol, Domical, Annoyltin, Amitriptyline HCl
T0678549-18-8
Amitriptyline hydrochloride (Annoyltin) is the hydrochloride salt of the tricyclic dibenzocycloheptadiene amitriptyline with antidepressant and antinociceptive activities.
5-HT ReceptorAChRAdrenergic ReceptorHistamine ReceptorNorepinephrineSerotonin TransporterSigma receptorSodium ChannelTrk receptor
- $45
Size
QTY
Fluoxetine hydrochloride Cited
LY-110140, Lilly110140, Fluoxetine HCl
T0450L56296-78-7
Fluoxetine hydrochloride (Lilly110140) is the first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
- $48
Size
QTY
CitedL-DOPA Cited
Levodopa, 3,4-Dihydroxyphenylalanine
T084859-92-7
L-DOPA (Levodopa) is an amino acid precursor of dopamine with antiparkinsonian properties. It is a prodrug converted to dopamine by DOPA decarboxylase and can cross the blood-brain barrier. In the brain, levodopa is decarboxylated to dopamine, stimulating dopaminergic receptors and compensating for depleted endogenous dopamine in Parkinson's disease. To ensure adequate concentrations reach the central nervous system, levodopa is administered with carbidopa, a decarboxylase inhibitor that does not cross the blood-brain barrier, reducing peripheral decarboxylation and increasing CNS dopamine delivery.
- $50
Size
QTY
CitedSelect Batch
Purity:98.78%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.Product Introduction
Bioactivity
Chemical Properties
| Description | 5-HT6/7 antagonist 1 is a dual 5-HT6/7/2A and D2 receptor antagonist used in the study of dementia and Alzheimer's disease. |
| In vitro | Constituting a promising strategy for treating symptoms of BPSD, targeting 5-HT6 and/or 5-HT7 receptors with antagonist drugs may avoid some of the side effects associated with current antipsychotic drugs. Nevertheless, given the complex pathology of dementia and the accompanying behavioral and psychological symptoms, it seems unlikely that focusing on a single therapeutic target would be sufficient to provide adequate clinical benefit. Therefore, the successful development of novel anti-BPSD agents is likely to involve a 'designed' multifactorial approach[1]. |
| Molecular Weight | 393.41 |
| Formula | C22H20FN3O3 |
| Cas No. | 131999-28-5 |
| Smiles | FC=1C=C2C(C(=NO2)C3CCN(CCN4C(=O)C=5C(C4=O)=CC=CC5)CC3)=CC1 |
Storage & Solubility Information
| Storage | Shipping with blue ice. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy 5-HT6/7 antagonist 1 | purchase 5-HT6/7 antagonist 1 | 5-HT6/7 antagonist 1 cost | order 5-HT6/7 antagonist 1 | 5-HT6/7 antagonist 1 chemical structure | 5-HT6/7 antagonist 1 in vitro | 5-HT6/7 antagonist 1 formula | 5-HT6/7 antagonist 1 molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.